20/20 Biolabs Inc. (AIDX) vs Aptevo Therapeutics Inc. (APVO)

A side-by-side comparison of 20/20 Biolabs Inc. and Aptevo Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
20/20 Biolabs Inc. logo
AIDX
20/20 Biolabs Inc.
$4M
$0.34HealthcareDelayed quote: Oct 6, 2026, 12:30 PM EDT
Aptevo Therapeutics Inc. logo
APVO
Aptevo Therapeutics Inc.
$4M
$1.83HealthcareDelayed quote: Oct 6, 2026, 12:42 PM EDT

Total return — AIDX vs APVO

growth of $100 · dividends reinvested · last 1y
AIDX -98.5% (-98.5%/yr)APVO -72.7% (-72.7%/yr)APVO compounded faster over this window
Log scale — wide-divergence pair
110100Start $100$1$27
AIDX APVO

AIDX vs APVO: by the numbers

  • •AIDX is the larger company ($4M vs $4M market cap).
  • •Both run net losses; APVO's is the smaller (0.00% vs -285.00% net margin).

Metrics side by side

Valuation

MetricAIDXAPVO
P/S ratio2.06N/A
P/B ratio2.600.66

Profitability

MetricAIDXAPVO
Gross margin31.52%0.00%
Operating margin-162.87%0.00%
Net margin-285.00%0.00%
ROE-184.04%-437.15%
ROIC-116.89%-288.14%

Growth (annualized)

MetricAIDXAPVO
Revenue CAGR (5Y)-2.58%N/A
Total return CAGR (5Y)N/A-95.30%

Go deeper

Full AIDX analysisFull APVO analysisInteractive comparison tool

Dig into the metrics

20/20 Biolabs ROEAptevo Therapeutics ROE20/20 Biolabs operating marginAptevo Therapeutics operating margin20/20 Biolabs revenue growthAptevo Therapeutics revenue growth20/20 Biolabs free cash flowAptevo Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.